ABBV

Why This Dividend ETF is Perfectly Balanced for Yield and Growth

09/10 06:23 am

The Schwab U.S. Dividend Equity ETF (SCHD) Is One of the Leading Blue Chip ETFs in 2025. Here's Why.

09/09 09:30 am

Should Passive Income Investors Be Concerned That 54% of the High-Yield Schwab U.S. Dividend Equity ETF Is in Just 3 Stock Market Sectors?

09/08 06:27 am

AbbVie Declares Quarterly Dividend

09/05 09:07 am

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

09/04 04:09 am

Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034

09/03 11:00 am

Healthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry

09/02 09:37 am

Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves

08/29 03:20 pm

Dermatology Market to Worth USD 2.75 Billion Size by 2034

08/29 11:00 am

As the Market Rotates, This Healthcare ETF Is Leading the Way

08/26 10:07 am

AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment

08/26 09:26 am

Viking Therapeutics: What's Next?

08/26 06:15 am

3 Top Stocks to Build Your Portfolio Around

08/24 09:15 am

Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight

08/21 01:00 pm

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

08/21 10:10 am

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035 | Over 140 Players Now Active in HPAPI & Cytotoxic Drug Contract Manufacturing

08/21 05:59 am

Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

08/20 10:00 am

Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030

08/19 01:54 pm

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

08/14 01:00 pm

Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.

08/12 08:00 am

AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules

08/08 02:00 pm

AbbVie Raises 2025 Outlook After Q2 Beat

08/04 11:23 am

AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion

08/01 02:04 pm

Deal Dispatch: MEG Bidding War Heats Up, L Catterton Takes Bite Out Of Kisshokichi, Sunnova's Still Shining

08/01 01:15 pm

Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options

08/01 05:00 am

Global Dermal Fillers Market is Predicted to Reach ~USD 12 Billion by 2032 | DelveInsight

07/31 01:00 pm

AbbVie Lifts Outlook, Eyes Parkinson's Assets As Next Growth Frontier

07/31 11:18 am

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

07/27 06:22 am

Oncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects

07/25 10:50 am

The Best High-Yield Dividend ETF to Own for the Next 10 Years

07/25 10:15 am

Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight

07/23 01:00 pm

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

07/23 12:51 pm

2 High-Yield Dividend ETFs That Could Deliver Steady Income for Decades

07/22 06:15 am

All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year

07/19 06:15 am

Ophthalmics Collaboration and Licensing Deals Report and Directory 2025 | Company A-Z, Therapy Focus, Upfront, Milestone, Royalties

07/18 04:58 am

3 Reasons the Schwab U.S. Dividend Equity ETF Is an Attractive Investment for Retirees

07/16 04:25 am

The Smartest Dividend Stocks to Buy With $300 Right Now

07/12 05:15 am

Why Is AbbVie Stock Trading Higher On Thursday?

07/10 02:36 pm

Biologic Competition, Payer Pressures, and Gene Therapy Momentum Define a Pivotal Moment in nAMD and DME Management, According to Spherix Global Insights

07/10 01:27 pm

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial

07/03 09:00 am

Questex’s Fierce Pharma Unveils Powerhouse Conference Program for the Inaugural Fierce Pharma Week, Where Pharma’s Future Takes Shape

06/23 10:00 am

Precision Medicine in Oncology Collaboration and Licensing Agreements Analysis Report 2025: Online Deal Records As Disclosed by the Deal Parties - Upfront, Milestone, Royalties

06/23 04:39 am

Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere

06/20 03:39 pm

Artificial Intelligence (AI) Collaboration, R&D, and Licensing Agreements Trends Report and Directory 2025 | Access to Actual Deals Signed by the World's Leading Biopharma Companies

06/19 10:58 am

AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes

06/17 10:43 am

Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight

06/12 01:00 pm

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)

06/11 05:07 pm

Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

06/10 04:53 am

CEREVEL ALERT: Bragar Eagel & Squire, P.C. is Investigating Cerevel Therapeutics Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

06/04 09:00 pm

Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc. (ABBV)

06/04 01:00 pm